Cancer Clinical Trials

247 studies are recruiting for cancer in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

Studies, page 7

1. Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated With Radiation

   Registry database repository for determining clinical outcomes primarily of patients who have received or have been evaluated for radiation treatment in either the definitive or palliative setting for both malignant and benign etiologies. To compare the outcomes with National Cancer Data Base (NCDB…

   Stage

   Not phased

   Ages

   18 to 99

   Site

   UT Southwestern Medical Centre, Dallas, Texas

   Run by

   University of Texas Southwestern Medical Center

   See if you can join NCT03617237 on ClinicalTrials.gov

2. A New Psychotherapy Intervention for Older Cancer Patients

   This study is being done to see if a new psychotherapy intervention called Cancer and Aging: Reflections for Elders (CARE) can effectively treat depression and distress in older cancer patients. CARE is a 5-session intervention that takes place over the phone. This study will compare CARE with the …

   Stage

   Not phased

   Ages

   70 and older

   Site

   Memorial Sloan Kettering Cancer Center, New York, New York

   Run by

   Memorial Sloan Kettering Cancer Center

   See if you can join NCT04452825 on ClinicalTrials.gov

3. Massage Impact on Sleep in Pediatric Oncology

   This study aims to determine the impact of massage therapy for pediatric patients receiving intensive chemotherapy or stem cell transplant (SCT).

   Stage

   Not phased

   Ages

   12 to 21

   Site

   Children's Hospital of Philadelphia, Philadelphia, Pennsylvania

   Locations

   2 in total

   Run by

   Children's Hospital of Philadelphia

   See if you can join NCT06892158 on ClinicalTrials.gov

4. Precision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing

   Precision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing

   Stage

   Not phased

   Ages

   18 and older

   Site

   Ohio State University Wexner Medical Center, Columbus, Ohio

   Run by

   Ohio State University Comprehensive Cancer Center

   See if you can join NCT02090530 on ClinicalTrials.gov

5. The Cancer Stage Shifting Initiative: Registry and Biorepository to Research and Address Health Disparities in Cancer Care

   The goal of this observational study is to establish a patient registry and a biorepository (sample collection and storage) to investigate health disparities, access, and barriers to cancer screening and early detection technologies. The registry and biorepository will serve as a resource to suppor…

   Stage

   Not phased

   Ages

   35 and older

   Site

   Life in 3D Health Services, Flint, Michigan

   Locations

   2 in total

   Run by

   National Minority Quality Forum

   See if you can join NCT07461493 on ClinicalTrials.gov

6. Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors

   The goal of this clinical trial is to learn if investigational drug called SYS6043 works in adults with advanced or metastatic solid tumors that have spread or cannot be treated with standard therapies. The main goals of the study are to understand how safe SYS6043 is, what side effects it may caus…

   Stage

   Phase 1

   Ages

   18 and older

   Site

   BRCR Global, Plantation, Florida

   Locations

   5 in total

   Run by

   Conjupro Biotherapeutics, Inc.

   See if you can join NCT07424547 on ClinicalTrials.gov

7. Arizona Cancer Center Biospecimen Repository

   RATIONALE: Collecting and storing samples of tissue and blood from patients with cancer to test in the laboratory may help the study of cancer in the future. PURPOSE: This research study is collecting and storing tumor, tissue, and blood samples from patients with pancreatic cancer.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Arizona Cancer Center at University of Arizona Health Sciences Center, Tucson, Arizona

   Run by

   University of Arizona

   See if you can join NCT00896935 on ClinicalTrials.gov

8. CTNow: A Clinical Trials Education Program for Rural Cancer Patients and Oncology Providers

   The overall goal of the project is to pilot test CTNow, a multilevel intervention designed to facilitate access and referrals to cancer clinical trials in rural areas through patient and provider education and teleconference resources.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Hilo Benioff Medical Center, Hilo, Hawaii

   Locations

   3 in total

   Run by

   University of Hawaii

   See if you can join NCT06237816 on ClinicalTrials.gov

9. Study of Personalized Cancer Therapy to Determine Response and Toxicity

   The purpose of this study is to learn more about personalized cancer therapy including response to treatment and side effects. Information about the tests and treatments a person received, or will receive, for their cancer will be collected from medical records to help the researchers determine whe…

   Stage

   Not phased

   Ages

   7 and older

   Site

   UCSD Moores Cancer Center, La Jolla, California

   Locations

   3 in total

   Run by

   Shu Mei Kato

   See if you can join NCT02478931 on ClinicalTrials.gov

10. Survivors Uniting for Remote Guided Exercise

    The goal of this research study is to look at how live, online group exercise compares to recorded videos for helping increase physical activity levels, improve physical fitness and quality of life, and reduce loneliness among those living with and beyond cancer. The following aims have been establ…

    Stage

    Not phased

    Ages

    18 and older

    Site

    Human Performance Clinical Research Lab, Fort Collins, Colorado

    Run by

    Colorado State University

    See if you can join NCT07290309 on ClinicalTrials.gov

11. Correlation Vitamin D Level to Endocrine Autoimmune Toxicity Due to Immune Checkpoint Inhibitors

    The purpose of this research study is to see if the amount of vitamin D in ones blood makes it more or less likely to develop thyroid gland toxicity when being treated with immunotherapy that blocks the activity of proteins called programed death-1(PD-1) or programmed death ligand-1 (PD-L1). Immuno…

    Stage

    Not phased

    Ages

    18 and older

    Site

    Mount Sinai Hospital /Tisch Cancer Cancer/Ruttenberg Treatment Center, New York, New York

    Run by

    Icahn School of Medicine at Mount Sinai

    See if you can join NCT04615988 on ClinicalTrials.gov

12. Enhancing Triadic Communication About Cognition for Older Adults With Alzheimer's Disease or Related Dementias Facing a Cancer Management Decision

    Building upon prior work, the investigator team developed a communication intervention for older adults with ADRD who are considering a decision about cancer management (adapted intervention: COACH-Cog). The investigators hypothesize that for patients with dual diagnoses of ADRD and cancer, COACH-C…

    Stage

    Not phased

    Ages

    65 and older

    Site

    University of Rochester Wilmot Cancer Institute, Rochester, New York

    Run by

    University of Rochester

    See if you can join NCT06313853 on ClinicalTrials.gov

13. A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors

    The goal of this clinical trial is to test CPO301, a type of drug called an antibody drug conjugate in adult patients with advanced or metastatic solid tumors. The main questions it aims to answer are: * To assess the safety and tolerability of CPO301 at increasing doses and determine the dose to b…

    Stage

    Phase 1

    Ages

    18 and older

    Site

    USC Norris Comprehensive Cancer Center, Los Angeles, California

    Locations

    14 in total

    Run by

    Conjupro Biotherapeutics, Inc.

    See if you can join NCT05948865 on ClinicalTrials.gov

14. An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors

    Phase 1, open-label dose-escalation study to determine the MTD of INV-1120 and RP2D, and to assess the DLT of INV-1120 as a single agent or in the combination with pembrolizumab. The safety, tolerability, and PK of INV-1120 as a single agent or in the combination with pembrolizumab will be assessed…

    Stage

    Phase 1

    Ages

    18 and older

    Site

    UT Health, San Antonio, Texas

    Locations

    3 in total

    Run by

    Shenzhen Ionova Life Sciences Co., Ltd.

    See if you can join NCT04443088 on ClinicalTrials.gov

15. The TIOB - Collection of Patients' Biospecimens for Analysis of Immunological and Molecular Biomarkers.

    The purpose of the Texas Immuno-Oncology Biorepository (TIOB) is to collect and store well-defined and well-annotated serial biospecimens of tissue, blood, urine and stool in a longitudinal manner from cancer patients who are receiving either standard of care surgical interventions and or FDA appro…

    Stage

    Not phased

    Ages

    18 and older

    Site

    Baylor Scott & White Medical Center - College Station, College Station, Texas

    Locations

    8 in total

    Run by

    Baylor Research Institute

    See if you can join NCT05371756 on ClinicalTrials.gov

16. Implementation of eHealth Delivery Alternatives for Cancer Genetic Testing for Hereditary Cancer (eREACH3)

    The purpose of the study is to understand patient interest in telehealth and digital tools for pre-test genetic education and/or disclosure of genetic test results. Participants will receive telehealth genetic counseling in the home and may be offered various digital tools to help with the counseli…

    Stage

    Not phased

    Ages

    18 and older

    Site

    Abramson Cancer Center at the University of Pennsylvania, Philadelphia, Pennsylvania

    Run by

    Abramson Cancer Center at Penn Medicine

    See if you can join NCT07471958 on ClinicalTrials.gov

17. A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)

    This study looks to advance a novel and potent strategy to eliminate minimal residual disease (MRD) in triple negative breast cancer (TNBC) present even after multimodal treatment, thereby improving survival and increasing cure rate in this aggressive cancer. Patients with locally advanced TNBC are…

    Stage

    Phase 1

    Ages

    18 to 99

    Site

    Los Angeles General Medical Center, Los Angeles, California

    Locations

    3 in total

    Run by

    University of Southern California

    See if you can join NCT04333706 on ClinicalTrials.gov

18. Supportive Care Intervention for Outpatient Stem Cell Transplant Patients

    The overall goal of this study is to assess the efficacy of the care.coach Avatar™ in improving anxiety and quality of life for patients undergoing outpatient transplant. After care.coach Avatar™ content and scheduling ("digital intervention" or "program") has been optimized for outpatient allogene…

    Stage

    Not phased

    Ages

    19 and older

    Site

    Dana-Farber Cancer Institute, Boston, Massachusetts

    Run by

    Victor Wang

    See if you can join NCT06564233 on ClinicalTrials.gov

19. Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions

    The purpose of this study is to determine whether a consultation with a Personalized Therapeutics Clinic, or PTC, will help participants lower the risk for side effects (drug-drug interactions and drug-gene interactions) when taking many medications and help providers improve prescribing decisions …

    Stage

    Not phased

    Ages

    18 and older

    Site

    University of Chicago Medicine, Chicago, Illinois

    Run by

    University of Chicago

    See if you can join NCT05166694 on ClinicalTrials.gov

20. Ovarian Tissue Cryopreservation for Fertility Preservation

    The goal of this observational study is to learn about fertility preservation for pre-pubertal, peri-pubertal, and adult participants that are unable to pursue clinical standard of care fertility preservation such as egg (oocyte) and embryo cryopreservation. In addition, this study will provide res…

    Stage

    Not phased

    Ages

    Up to 39

    Site

    Magee-Womens Hospital, Pittsburgh, Pennsylvania

    Run by

    University of Pittsburgh

    See if you can join NCT05875155 on ClinicalTrials.gov

21. Modernizing Instructions to Improve Treatment Participation of Subjects During Their First Radiotherapy

    Daily patient participation is critical to the successful, life-saving delivery of radiotherapy. There is very little in the literature describing the best way to prepare patients to give optimal participation. This study aims to look at an already-prepared conversion of patient instruction materia…

    Stage

    Not phased

    Ages

    18 to 99

    Site

    University of Florida, Gainesville, Florida

    Run by

    University of Florida

    See if you can join NCT06246409 on ClinicalTrials.gov

22. Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors

    This is a first-in-human (FIH), open label Phase 1/1b / Phase 2 study in patients with advanced metastatic solid tumors refractory to standard treatment. Phase 1 will identify potential optimal biologically relevant doses (OBRD) and the maximum tolerated dose (MTD) of MBRC-101 at one 1 or more dosi…

    Stage

    Phase 1

    Ages

    18 and older

    Site

    UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California

    Locations

    17 in total

    Run by

    MBrace Therapeutics

    See if you can join NCT06014658 on ClinicalTrials.gov

23. Positron Emission Tomography (PET) Imaging of Thrombosis

    The purpose of the study is to evaluate a new radiotracer called 64Cu-FBP8 for PET-MR imaging of thrombosis. The tracer has the potential of detecting thrombosis anywhere in the body, for instance in the left atrial appendage of patients with atrial fibrillation, and thereby may provide a non-invas…

    Stage

    Phase 1

    Ages

    18 to 85

    Site

    Massachusetts General Hospital, Boston, Massachusetts

    Run by

    Massachusetts General Hospital

    See if you can join NCT03830320 on ClinicalTrials.gov

24. Cultural Tailoring and Pilot Testing of an Inpatient Yoga Therapy Program for Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation in India, Tanzania, and the United States

    To develop and measure the effects of a culturally sensitive yoga program for inpatients

    Stage

    Not phased

    Ages

    18 and older

    Site

    M D Anderson Cancer Center, Houston, Texas

    Locations

    3 in total

    Run by

    M.D. Anderson Cancer Center

    See if you can join NCT05681026 on ClinicalTrials.gov

25. Food and Microbiome Longitudinal Investigation (FAMiLI)

    The NYU Human Microbiome Study Cohort is designed to improve understanding of the role of human microbiome in health and disease. This study will serve as a critical NYU biorepository resource for research on human genetics and the microbiome in health and disease

    Stage

    Not phased

    Ages

    40 and older

    Site

    New York University School of Medicine, New York, New York

    Run by

    NYU Langone Health

    See if you can join NCT03293758 on ClinicalTrials.gov